Japan vs Trinidad and Tobago: Share of adolescent girls vaccinated against human papillomavirus
Japan
22.0%
in 2024
Trinidad and Tobago
16.0%
in 2024
Japan rank
66th
Trinidad and Tobago rank
68th
Share of adolescent girls vaccinated against human papillomavirus over time
- Japan
- Trinidad and Tobago
How they compare
Japan currently reports 22.0% against 16.0% in Trinidad and Tobago, a difference of 6.0%.
That makes Japan's figure about 1.4 times Trinidad and Tobago's.
The two have swapped places 1 time across 6 shared years of data; in 2019 it was Trinidad and Tobago ahead.
Japan ranks 66th and Trinidad and Tobago ranks 68th of 74 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 6.0% | 6.0% | Trinidad and Tobago |
| 2020s | 8.0% | 11.4% | 3.4% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Japan or Trinidad and Tobago?
- Japan, at 22.0% against 16.0% in Trinidad and Tobago as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Japan and Trinidad and Tobago?
- 6.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Trinidad and Tobago?
- 6 years are reported by both, from 2019 to 2024.
- How do Japan and Trinidad and Tobago rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Japan ranks 66th and Trinidad and Tobago ranks 68th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.